William Blair analyst Sami Corwin has maintained their bullish stance on CRSP stock, giving a Buy rating on January 14.Stay Ahead of the ...
Molecular Partners' DARPin platform shows promise, but future funding is uncertain. Learn why MOLN stock could be a risky, ...
As 2025 begins, the American Association for Cancer Research (AACR) recently published forecasts from experts showcasing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback